RT Journal
A1 Wang B, Gagne JJ, Choudhry NK
T1 THe epidemiology of drug recalls in the united states
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2012
FD July 23
VO 172
IS 14
SP 1110
OP 1111
DO 10.1001/archinternmed.2012.2013
UL http://dx.doi.org/10.1001/archinternmed.2012.2013
AB 
On January 31, 2012, Pfizer recalled nearly 1 million packs of birth control pills because of concerns that inert and active pills were miscounted and incorrectly ordered in their blister packs.1 This and other recent recalls highlight concerns about the potential clinical impact of defective and otherwise compromised drug products. However, little is known about the public health burden of drug recalls and whether health care providers are properly notified about clinically important recalls. We sought to quantify the frequency, cause, and extent of distribution of drug recalls in the United States and to evaluate the processes by which the US Food and Drug Administration (FDA) communicates clinically important recall information to health care providers.